Overview

Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants

Status:
Withdrawn
Trial end date:
2019-02-13
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well carrageenan-containing gel (vaginal gel) works in reducing the rate of human papilloma virus (HPV) infection in healthy participants. Carrageenans, which are naturally derived from seaweed, are enhancements to natural lubrication and may be effective in blocking HPV infection.
Phase:
Phase 2
Details
Lead Sponsor:
Albert Einstein College of Medicine of Yeshiva University
Rutgers, The State University of New Jersey
Collaborator:
National Cancer Institute (NCI)